David OReilly - British American Group Scientific Director

BTAFF Stock  USD 36.02  0.92  2.49%   

Director

Dr. David OReilly is an Group Scientific Director of British American Tobacco Plc. He was appointed Group Scientific Director in January 2012. He was with British American Tobacco for over 20 years and has held various positions in Group Research and Development. He has led the Groups RD efforts to develop reduced toxicant products and has also been Head of International Public Health Scientific Affairs, responsible for engagement with the scientific, medical and public health communities. since 2012.
Age 57
Tenure 12 years
Professional MarksPh.D
Phone44 20 7845 1000
Webhttps://www.bat.com

David OReilly Latest Insider Activity

Tracking and analyzing the buying and selling activities of David OReilly against British American pink sheet is an integral part of due diligence when investing in British American. David OReilly insider activity provides valuable insight into whether British American is net buyers or sellers over its current business cycle. Note, British American insiders must abide by specific rules, including filing SEC forms every time they buy or sell British American'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

British American Management Efficiency

The company has return on total asset (ROA) of 0.0501 % which means that it generated a profit of $0.0501 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0957 %, meaning that it generated $0.0957 on every $100 dollars invested by stockholders. British American's management efficiency ratios could be used to measure how well British American manages its routine affairs as well as how well it operates its assets and liabilities.
British American Tobacco has accumulated 38.35 B in total debt with debt to equity ratio (D/E) of 0.61, which is about average as compared to similar companies. British American Tobacco has a current ratio of 0.86, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist British American until it has trouble settling it off, either with new capital or with free cash flow. So, British American's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like British American Tobacco sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for British to invest in growth at high rates of return. When we think about British American's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

H DiaoTurning Point Brands
63
Jack BowlesBritish American Tobacco
60
Tadeu MarrocoBritish American Tobacco
58
Robert SleddUniversal
67
Diana CantorUniversal
62
Peter DurmanImperial Brands PLC
N/A
Savio KwanBritish American Tobacco
72
Lisa HookPhilip Morris International
63
Kalpana MorpariaPhilip Morris International
71
Johan VandermeulenBritish American Tobacco
56
Jun MakiharaPhilip Morris International
63
James BarrettBritish American Tobacco
49
Luc JobinBritish American Tobacco
61
Stephen UsherTurning Point Brands
54
Dimitri PanayotopoulosBritish American Tobacco
69
Jerome AbelmanBritish American Tobacco
60
Michael LawtonUniversal
61
Dessislava TemperleyPhilip Morris International
48
Ashley FrushoneTurning Point Brands
46
Jennifer LiPhilip Morris International
52
Luciano CominBritish American Tobacco
54
British American Tobacco p.l.c. provides tobacco and nicotine products to consumers worldwide. British American Tobacco p.l.c. was incorporated in 1902 and is headquartered in London, the United Kingdom. British American operates under Tobacco classification in the United States and is traded on OTC Exchange. It employs 54365 people. British American Tobacco [BTAFF] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

British American Tobacco Leadership Team

Elected by the shareholders, the British American's board of directors comprises two types of representatives: British American inside directors who are chosen from within the company, and outside directors, selected externally and held independent of British. The board's role is to monitor British American's management team and ensure that shareholders' interests are well served. British American's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, British American's outside directors are responsible for providing unbiased perspectives on the board's policies.
Luciano Comin, Regional Director - Americas and Sub Saharan Africa (AMSSA)
Guy Meldrum, Regional Director - Asia-Pacific and Middle East
David OReilly, Group Scientific Director
Tadeu Marroco, Business Development Director
Paul Lageweg, Director - New Categories
Kingsley Wheaton, Managing Director of Next Generation Products and Member of Management Board
Jerome Abelman, Group Corporate & Regulatory Affairs Director
Jack Bowles, Regional Director of Asia Pacific and Member of the Management Board
Johan Vandermeulen, Regional Director - EEMEA
Hae Kim, Director - Talent and Culture

British Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is British American a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in British Pink Sheet

When determining whether British American Tobacco offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of British American's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of British American Tobacco Stock. Outlined below are crucial reports that will aid in making a well-informed decision on British American Tobacco Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in British American Tobacco. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Please note, there is a significant difference between British American's value and its price as these two are different measures arrived at by different means. Investors typically determine if British American is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, British American's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.